Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2025-03-18 2025-03-18
Drug Identification Number 02541084 02541084
Brand name MOUNJARO MOUNJARO
Common or Proper name tirzepatide injection tirzepatide injection
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients TIRZEPATIDE TIRZEPATIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 3 mL single-dose vial 3 mL single-dose vial
ATC code A10BX A10BX
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2025-04-02 2025-04-02
Actual start date 2025-03-17 2025-03-17
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Due to an increase in demand and limited inventory of Mounjaro 10 mg vials. All doses of KwikPen 2.5 mg to 12.5 mg are available and KwikPen supply will be prioritized moving forward. For any questions, please contact our Lilly Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). Due to an increase in demand and limited inventory of Mounjaro 10 mg vials. All doses of KwikPen 2.5 mg to 12.5 mg are available and KwikPen supply will be prioritized moving forward. For any questions, please contact our Lilly Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments